DTIL - Company ID 0001357874
The table below shows PRECISION BIOSCIENCES INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $10.84M | $13.00K | $18.00K | $29.00K |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $12.74M | $12.39M | $13.11M | $13.35M | $12.77M | $13.59M |
PRECISION BIOSCIENCES INC reported annual revenue of $34.26M for fiscal year 2025. That is down 50.1% from $68.70M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $10.88M (FY 2018) to $34.26M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $7.68M |
| $6.77M |
| $6.80M |
| $7.33M |
| $9.13M |
| $8.55M |
| Operating income | -$20.43M | -$19.16M | -$9.07M | -$20.67M | -$21.88M | -$22.11M |
| Income tax | - | - | - | - | - | - |
| Net income | -$7.59M | -$32.65M | -$18.44M | -$21.77M | -$23.52M | -$20.57M |
| EPS (diluted) | -$0.28 | -$1.26 | -$0.75 | -$1.84 | -$2.13 | -$2.21 |